Humphrey Rachel

DirectorPyxis Oncology, Inc. (PYXS) · full profile →Form 4 · filed Mar 25, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$16K
Net Open-Market Flow
-$16K
Transactions
3
3 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Apr 21, 2025Sell(S)14K$1.03$14K81K
Apr 17, 2025Sell(S)200$0.97$19495K
Apr 14, 2025Sell(S)1K$0.97$1K95K

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000905148-26-001434) within minutes of acceptance. Every field above traces to the original document. Verify it directly: